Publication:
COVID-19 vaccine hesitancy in Spain and associated factors

dc.contributor.authorFalcón, María
dc.contributor.authorRodriguez-Blazquez, Carmen
dc.contributor.authorRomay-Barja, Maria
dc.contributor.authorAyala, Alba
dc.contributor.authorBurgos Llamo, Alfredo
dc.contributor.authorTena-Davila, Maria José de
dc.contributor.authorForjaz, Maria João
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2023-04-18T11:00:44Z
dc.date.available2023-04-18T11:00:44Z
dc.date.issued2023-03-16
dc.description.abstractIntroduction: The present study explores the reasons of those who have not been vaccinated in the later stage of the vaccine rollout in Spain and its associated determinants. Methods: Cluster and logistic regression analyses were used to assess differences in claimed reasons for vaccine hesitancy in Spain using two samples of unvaccinated people (18-40 years old) gathered by an online cross-sectional survey from social networks (n = 910) and from a representative panel (n = 963) in October-November 2021. Results: The main reasons for not being vaccinated were believing that the COVID-19 vaccines had been developed too fast, they were experimental, and they were not safe, endorsed by 68.7% participants in the social network sample and 55.4% in the panel sample. The cluster analysis classified the participants into two groups. Logistic regression showed that Cluster 2 (individuals who reported structural constraints and health-related reasons such as pregnancy or medical recommendation) presented a lower trust in information from health professionals, had a lower willingness to get vaccinated in the future, and avoided less social/family events than those in Cluster 1 (reasons centered in distrust on COVID-19 vaccines, conspiracy thoughts and complacency). Conclusions: It is important to promote information campaigns that provide reliable information and fight fake news and myths. Future vaccination intention differs in both clusters, so these results are important for developing strategies target to increase vaccination uptake for those who do not reject the COVID-19 vaccine completely.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThe research was funded by Carlos III Health Institute. This study was also partially funded by RICAPPS (Carlos III Health Institute, ref: RD21CIII/0003/0002). The funder had no role in the study design; collection, analysis, and interpretation of data; writing of the paper; and/or decision to submit for publication.es_ES
dc.format.page1129079es_ES
dc.format.volume11es_ES
dc.identifier.citationFront Public Health. 2023 Mar 16;11:1129079.es_ES
dc.identifier.doi10.3389/fpubh.2023.1129079es_ES
dc.identifier.e-issn2296-2565es_ES
dc.identifier.journalFrontiers in public healthes_ES
dc.identifier.pubmedID37006532es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15836
dc.language.isoenges_ES
dc.publisherFrontiers Media
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/RD21CIII/0003/0002es_ES
dc.relation.publisherversionhttps://doi.org/10.3389/fpubh.2023.1129079es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiología (CNE)es_ES
dc.repisalud.centroISCIII::Centro Nacional de Medicina Tropical (CNMT)es_ES
dc.repisalud.centroISCIII::Unidad de Investigación en Telemedicina y eSaludes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19es_ES
dc.subjectBehavioral insightses_ES
dc.subjectHesitancyes_ES
dc.subjectPublic healthes_ES
dc.subjectVaccinees_ES
dc.subject.meshCOVID-19 Vaccineses_ES
dc.subject.meshCOVID-19es_ES
dc.subject.meshFemalees_ES
dc.subject.meshPregnancyes_ES
dc.subject.meshHumanses_ES
dc.subject.meshAdolescentes_ES
dc.subject.meshYoung Adultes_ES
dc.subject.meshAdultes_ES
dc.subject.meshSpaines_ES
dc.subject.meshCross-Sectional Studieses_ES
dc.subject.meshCluster Analysises_ES
dc.titleCOVID-19 vaccine hesitancy in Spain and associated factorses_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication29e894ba-7954-479f-b6e1-34df229abf98
relation.isAuthorOfPublication2611f71f-675d-4029-a350-bc28929074ad
relation.isAuthorOfPublication88f80e70-adbb-4a33-8f2f-3ca9e26b356a
relation.isAuthorOfPublication1c4919b9-1c46-47d1-ac06-7523be883f41
relation.isAuthorOfPublication16cb2ba7-777d-4912-ac39-11335a3dd901
relation.isAuthorOfPublication.latestForDiscovery29e894ba-7954-479f-b6e1-34df229abf98
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication.latestForDiscovery7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isPublisherOfPublication9f9fa5ea-093b-43d8-bf2c-5bd65d08a802
relation.isPublisherOfPublication.latestForDiscovery9f9fa5ea-093b-43d8-bf2c-5bd65d08a802

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
COVID-19_VaccineHesitancy_2023.pdf
Size:
355.26 KB
Format:
Adobe Portable Document Format
Description: